NEW YORK (Reuters Health) - Many children and teens using insulin pumps to control type 1 diabetes experience skin problems at the infusion catheter insertion site, but few report thinking about ...

A mobile app used with an insulin pump that led to 224 injuries was recalled by Tandem Diabetes Care, the FDA announced today. The recall is for the 2.7 version of the Apple iOS t:connect mobile app, ...

Before eating a healthy lunch with friends, Megan Fisher, a senior mechanical engineering major, slipped away quietly to check her insulin pump, a tedious chore she must perform before every meal.

The US Food and Drug Administration (FDA) has issued a Class I recall for the t:connect mobile app on iOS, which is used to monitor and control the t:slim X2 insulin pump used by people with diabetes.

Please provide your email address to receive an email when new articles are posted on . Tandem Diabetes Care recalled a version of its t:connect mobile app in March ...

Add Yahoo as a preferred source to see more of our stories on Google. Tandem Diabetes Care plans to add a tubeless option for its Mobi insulin pump. Tandem Diabetes Care issued an urgent medical ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

According to the US FDA, at least 224 diabetes patients suffered from injuries linked to a glitch on t:connect iOS which shut down insulin pumps prematurely. isens usa from Unsplash Insulin pumps are ...

Medtronic (NYSE:MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened battery life. The medical device maker said an investigation into the issue ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to ...

There is variation in how automated insulin delivery algorithms operate, and diabetes care and education specialists should ...

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), has emerged as a significant advancement in diabetes technology over the last 50 years. Although commercial insulin ...